Arcadia Biosciences, Inc. — Director's Dealing 2018

Mar 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-03-23

Reporting Person: Lu Zhongjin (VP Product Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-23	Common Stock	M	1750	$21.60	Acquired	2308	Direct
2018-03-23	Common Stock	S	1750	$32.74	Disposed	558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-23	Employee Stock Option (right to buy)	$21.60	M	1750	Disposed	2018-06-30	Common Stock (1750)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $33.12 to $32.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The option is fully exercisable as of the date hereof.